29 results
8-K
EX-99.1
TSBX
Turnstone Biologics Corp.
14 Aug 24
Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
4:18pm
. There were also no new safety observations in the Phase I trial specific to TIDAL-01, and the Company demonstrated consistent manufacturing success … and which have not yet been approved for marketing by the U.S. Food and Drug Administration. No representation is made as to the safety or effectiveness
8-K
EX-99.2
TSBX
Turnstone Biologics Corp.
14 Aug 24
Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
4:18pm
STARLING trial is an ongoing multi-site, first-in-human, non-randomized, open label, single-dose study, and is evaluating the safety, tolerability … was generally well-tolerated and safety events observed were consistent with known AEs associated with the lymphodepletion regimen, and IL-2 and pembrolizumab
8-K
EX-99.1
TSBX
Turnstone Biologics Corp.
13 May 24
Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
5:03pm
and Drug Administration. No representation is made as to the safety or effectiveness of these product candidates for the uses for which they are being
10-K
5fdywu5i
21 Mar 24
Annual report
8:51pm
8-K
EX-99.1
y9g18l0b
21 Mar 24
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights
5:14pm
8-K
EX-99.1
n0nkfjf
5 Mar 24
Regulation FD Disclosure
8:30am
10-Q
ybr0e3ks byydou
1 Sep 23
Quarterly report
4:39pm
8-K
EX-3.2
qa6jhxq
25 Jul 23
Amendments to Articles of Incorporation or Bylaws
4:15pm
424B4
06uo2g7nspfg3x2g74
21 Jul 23
Prospectus supplement with pricing info
7:14pm
S-1/A
vtrq tqth7
23 Jun 23
IPO registration (amended)
9:49pm
S-1/A
EX-3.4
sod1ny4ss8fj
23 Jun 23
IPO registration (amended)
9:49pm
CORRESP
5swmnq3i9n dto7lp85
23 Jun 23
Correspondence with SEC
12:00am
UPLOAD
fov9zp641n
22 Jun 23
Letter from SEC
12:00am
S-1
EX-10.9
kmhw4pt7qx441p547w9o
12 Jun 23
IPO registration
4:28pm
S-1
EX-2.1
3x1y9 pw0k80o
12 Jun 23
IPO registration
4:28pm
S-1
vj8f52ez8jshaew9n
12 Jun 23
IPO registration
4:28pm